Job description

Requirements

  • Entry level
  • No Education
  • Salary to negotiate
  • Shanghai

Description

简介 Job Summary :

         阿斯利康  是一家以创新为驱动的全球综合型生物制药企业,不但拥有一支业内领先的庞大研发团队,更注重合作,先后有数位诺贝尔奖获得者曾和阿斯利康一起为创新药物产品的研发贡献力量。阿斯利康致力于研制、开发、生产和营销卓有成效的处方药品,并提供专业的医疗服务,在消化、心血管、中枢神经、呼吸、肿瘤、麻醉和抗感染等领域处于领先地位,名列《财富》杂志全球500强。 目前,SYM South 团队正在招募汕尾MR,欢迎有兴趣的候选人应聘,谢谢!

主要职责:

1.负责在指定的治疗领域和区域内开展公司产品的推广活动,最大程度地实现AstraZeneca产品的销售增长及市场占有率的提高;

2.以公司批准的用途、用法为准则,准确地向工作对象提供药物的特点、疗效及注意事项等资料,并告知医生有关的禁忌症、副作用及预防措施。

基本要求:

1.大专或大专以上学历,一年以上相关产品的推广经验;

2.良好的沟通能力和敬业精神,具有独立分析和解决问题的能力;

3.有一定的英语和计算机能力,医学、药学、生物等相关专业者优先。

4. 具备入职后能办理招商银行信用卡的资格(通过报销的业务消费必须使用公司商务信用卡)。

福利Benefits:


- 定期体检
- 医疗保险及子女医疗保险
- 企业年金
- 通讯补贴
- 补充商业保险投递方式 Application Channel:官网投递

生效日期Date Posted: 2019.7

截止日期Closing Date: 2019.9


AstraZeneca is an equal opportunity employer. AstraZeneca will consider all qualified applicants for employment without discrimination on grounds of disability, sex or sexual orientation, pregnancy or maternity leave status, race or national or ethnic origin, age, religion or belief, gender identity or re-assignment, marital or civil partnership status, protected veteran status (if applicable) or any other characteristic protected by law.

阿斯利康是一家提供平等机会的企业,我们将考虑所有符合条件的求职者就业。不因残疾、性别或性取向、怀孕或产假状况、种族或民族或族裔出身、年龄、宗教或信仰、性别认同或变更、婚姻或伴侣关系、受保护的退伍军人身份(如果适用)及任何其他受法律保护的特征而产生歧视。

  • ms project

About the company

AstraZeneca is a global, science-led biopharmaceutical company that spans the discovery, development, manufacturing, distribution and worldwide commercialisation of primary care and speciality care medicines.

We believe the best way we can help patients is to focus on breakthrough science in order to uncover disease mechanisms and develop novel, targeted therapies that interact with them. This is at the heart of our purpose as a company: to push the boundaries of science to deliver life-changing medicines.

We invest in distinctive science in three main therapy areas where we believe we can make the most meaningful difference to patients: oncology; cardiovascular and metabolic diseases; and respiratory, inflammation and autoimmunity. Our science exploits our rare combination of capabilities in small molecules and biologics, immunotherapies, protein engineering technologies and devices. These are reinforced by a strong focus on translational science and personalised healthcare capabilities. We build on our own capabilities by collaborating with world-renowned scientists and academic institutions and partnering with like-minded science-led companies.

Through leading in science, we are confident that we can transform the lives of people around the world and deliver value to our shareholders.